A. Aga

发表

Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis.

Ø. Skare, D. M. van der Heijde, H. B. Hammer, 2020, Rheumatology.

Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis

Inge Christoffer Olsen, D. M. van der Heijde, H. B. Hammer, 2017, Annals of the rheumatic diseases.

First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach

D. M. van der Heijde, H. B. Hammer, T. Kvien, 2015, Annals of the rheumatic diseases.

The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy

G. Serre, A. Catrina, J. Sexton, 2018, Arthritis Research & Therapy.

Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach

D. M. van der Heijde, T. Kvien, T. Uhlig, 2016, RMD Open.

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

H. B. Hammer, T. Kvien, T. Uhlig, 2021, Annals of the Rheumatic Diseases.

The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study

S. Ramiro, G. Burmester, M. Backhaus, 2022, Arthritis Research & Therapy.

Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria

Inge Christoffer Olsen, D. M. van der Heijde, H. B. Hammer, 2016, Annals of the rheumatic diseases.

Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol

Inge Christoffer Olsen, D. M. van der Heijde, H. B. Hammer, 2018, Rheumatology.

Disease management in early rheumatoid arthritis. Development and implementation of novel treatment strategies

A. Aga, 2016 .

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

H. B. Hammer, T. Kvien, T. Uhlig, 2022, RMD Open.

Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells

B. Lie, S. Rayner, A. Franke, 2020, Frontiers in Immunology.

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

Inge Christoffer Olsen, T. Kvien, T. Uhlig, 2013, Annals of the rheumatic diseases.

Achievement of Remission in Two Early Rheumatoid Arthritis Cohorts Implementing Different Treat‐to‐Target Strategies

D. Solomon, T. Kvien, T. Uhlig, 2020, Arthritis & rheumatology.

Clinical recommendations

T. Kvien, T. Uhlig, E. Haavardsholm, 2020, Oxford Textbook of Rheumatoid Arthritis.

MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients

B. Lie, S. Rayner, M. Zucknick, 2021, Frontiers in Immunology.

Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial

Inge Christoffer Olsen, D. M. van der Heijde, T. Kvien, 2016, British Medical Journal.

Response to: ‘Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis’ by Chevreau et al

D. M. van der Heijde, T. Kvien, B. Fevang, 2018, Annals of the rheumatic diseases.

Assessing synovitis in the hands in patients with rheumatoid arthritis by ultrasound: an agreement study exploring the most inflammatory active side from two Norwegian trials

L. Terslev, R. Christensen, J. Sexton, 2019, Arthritis Research & Therapy.

FRI0060 Trends in baseline disease activity, response and remission rates in rheumatoid arthritis (RA) during the last decade: Results from the nor-DMARD register

T. Uhlig, T. Kvien, A. Aga, 2013 .

Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy

D. M. van der Heijde, T. Kvien, J. Sexton, 2021, RMD Open.

Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS)

P. Conaghan, M. Østergaard, P. Junker, 2019, The Journal of Rheumatology.

THU0506 In an Inception Cohort of 175 DMARD NaÏve Ra Patients Classified According to the 2010 ACR/EULAR Criteria a Large Proportion of Patients does not Fulfill the 1987 ACR Criteria

D. M. van der Heijde, T. Uhlig, T. Kvien, 2013 .

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.

Inge Christoffer Olsen, D. M. van der Heijde, D. Solomon, 2021, JAMA.

The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis

Inge Christoffer Olsen, D. M. van der Heijde, T. Kvien, 2018, Arthritis & rheumatology.

Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control.

J. Sexton, D. H. Solomon, E. Haavardsholm, 2023, JAMA.

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes

Inge Christoffer Olsen, D. M. van der Heijde, T. Kvien, 2018, Annals of the rheumatic diseases.

Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis

J. Roth, V. Lilleby, B. Flatø, 2021, RMD Open.

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

Inge Christoffer Olsen, D. M. van der Heijde, T. Kvien, 2018, RMD Open.

Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD

Y. Hu, Ø. Molberg, T. Kvien, 2022, The Journal of Rheumatology.

Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study

T. Kvien, J. Sexton, E. Haavardsholm, 2018, RMD Open.

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Inge Christoffer Olsen, J. Lampa, M. Nurmohamed, 2023, Annals of the Rheumatic Diseases.

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

D. M. van der Heijde, D. Solomon, T. Kvien, 2023, Annals of the Rheumatic Diseases.